ETON PHARMACEUTICALS INC. - COMMON STOCK
14.52
30-七月-25 13:45:00
15 分钟延时
股票
+0.09
+0.62%
今日范围
14.25 - 14.89
ISIN
N/A
来源
NASDAQ
-
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025
28 7月 2025 04:00:00 条件 Nasdaq GlobeNewswire
-
08 7月 2025 03:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes
27 6月 2025 03:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
28 5月 2025 14:28:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences
14 5月 2025 13:30:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
13 5月 2025 13:01:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
01 5月 2025 13:30:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
28 4月 2025 03:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
01 4月 2025 04:00:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
18 3月 2025 03:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
14 3月 2025 03:50:00 条件 Nasdaq GlobeNewswire
-
04 3月 2025 03:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules
03 3月 2025 03:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
07 2月 2025 03:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400
06 2月 2025 03:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
03 1月 2025 03:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
20 12月 2024 03:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial
17 12月 2024 03:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
03 12月 2024 03:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
25 11月 2024 03:50:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >